Menstrual migraine: A review of prophylactic therapies

Current Pain and Headache Reports

Volumn 8, Issue 3, 2004, Pages 229-237

  Martin, Vincent T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CONJUGATED ESTROGEN; DIHYDROERGOTAMINE; ELETRIPTAN; ERGOT DERIVATIVE; ESTRADIOL; ESTROGEN; FROVATRIPTAN; MAGNESIUM; MINERAL; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PLACEBO; PROSTAGLANDIN; RIZATRIPTAN; SEROTONIN AGONIST; SUMATRIPTAN; TAMOXIFEN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOLMITRIPTAN;

ANALGESIA; BLEEDING DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ESTROGEN RELEASE; FUNCTIONAL DISEASE; HORMONAL THERAPY; HUMAN; MENSTRUAL CYCLE; MENSTRUATION DISORDER; MIGRAINE; NAUSEA; PATHOGENESIS; PATHOPHYSIOLOGY; PHOTOPHOBIA; PREMENSTRUAL SYNDROME; PREVALENCE; PROPHYLAXIS; PROSTAGLANDIN RELEASE; REVIEW; SHORT COURSE THERAPY; TREATMENT FAILURE; TREATMENT PLANNING; VOMITING;

EID: 3142703595     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-004-0057-1     Document Type: Review

References (70)

1. Silberstein SD, Merriam GR: Estrogens, progestins, and headache. Neurology 1991, 41:786-793.
2. Nattero G: Menstrual headache. In Advances in Neurology. Edited by Critchley M. New York: Raven Press; 1982:215-226.
3. Silberstein S, Merriam G: Sex hormones and headache (menstrual migraine). Neurology 1999, 53(suppl 1):S3-S13.
4. MacGregor EA: Menstruation, sex hormones, and migraine. Neurol Clin 1997, 15:125-141.
5. Somerville BW: The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972, 22:355-365.
6. Somerville BW: The role of progesterone in menstrual migraine. Neurology 1971, 21:853-859.
7. Lichten EM, Lichten JB, Whitty A, et al.: The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test. Headache 1996, 36:367-371.
8. Li W, Zheng T, Altura BM, et al.: Sex steroid hormones exert biphasic effects on cytosolic magnesium ions in cerebral vascular smooth muscle cells: possible relationships to migraine frequency in premenstrual syndromes and stroke incidence. Brain Res Bull 2001, 54:83-89.
9. Benedetto C, Allais G, Ciochetto D, et al.: Pathophysiological aspects of menstrual migraine. Cephalalgia 1997, 17(suppl 20):32-34.
10. Nattero G, Allais G, De Lorenzo C, et al.: Relevance of prostaglandins in true menstrual migraine. Headache 1989, 29:233-238.
11. Carlson LA, Ekelund LG, Oro L: Clinical and metabolic effects of different doses of prostaglandin E1 in man: prostaglandin and related factors. Acta Med Scand 1968, 183:423-430.
12. Irwin J, Morse E, Riddick D: Dysmenorrhea induced by autologous transfusion. Obstet Gynecol 1981, 58:286-290.
13. MacGregor EA, Chia H, Vohrah RC, et al.: Migraine and menstruation: a pilot study. Cephalalgia 1990, 10:305-310.
14. International Headache Society Subcommittee: The international classification of headache disorders. Cephalalgia 2004, 24(suppl 1):139.
15. Dzoljic E, Sipetic S, Vlajinac H, et al.: Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache 2002, 42:185-193.
16. Granella F, Sances G, Zanferrari C, et al.: Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993, 33:385-389.
17. Granella F, Sances G, Pucci E, et al.: Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000, 20:701-707.
18. Cupini LM, Matteis M, Troisi E, et al.: Sex-hormone-related events in migrainous females: a clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 1995, 15:140-144.
19. Mattsson P: Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache 2003, 43:27-35.
20. Koseoglu E, Nacar M, Talaslioglu A, et al.: Epidemiological and clinical characteristics of migraine and tension-type headache in 1146 females in Kayseri, Turkey. Cephalalgia 2003, 23:381-388.
21. Johannes CB, Linet MS, Stewart WF, et al.: Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology 1995, 45:1076-1082.
22. Couturier EG, Bomhof MA, Neven AK, et al.: Menstrual migraine in a representative Dutch population sample: prevalence, disability, and treatment. Cephalalgia 2003, 23:302-308.
23. Stewart WF, Lipton RB, Chee E, et al.: Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000, 55:1517-1523.
24. Granella F, Sances G, Allais G, et al.: Characteristics of menstrual and non menstrual attacks in women with menstrually related migraine [Abstract]. Cephalalgia 2001, 21:263-264.
25. Silberstein SD, Armellino JJ, Hoffman HD, et al.: Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Clin Ther 1999, 21:475-491.
26. Solbach MP, Waymer RS: Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan. Obstet Gynecol 1993, 82:769-772.
27. Silberstein SD, Massiou H, Le Jeunne C, et al.: Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 2000, 96:237-242.
28. Loder E, Silberstein S: Clinical Efficacy of 2.5 and 5 mg zolmitriptan in migraine associated with menses or in patients using non-progestogen contraceptives [Abstract]. Neurology 1998, 50(suppl 4):A341.
29. Massiou H, Pitei D, Poole P, et al.: Efficacy of eletriptan for the treatment of migraine in women with menstrually associated migraine, and in women on contraceptives hormone replacement therapy: meta-analysis of randomized clinical trials [Abstract]. Cephalalgia 2000, 20:435.
30. Gross M, Barrie M, Bates D, et al.: The efficacy of oral sumatriptan in menstrual migraine: a prospective study [Abstract]. Cephalalgia 1995, 15(suppl 4):227.
31. Silberstein SD, Massiou H, McCarroll KA, et al.: Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data. Headache 2002, 42:917-923.
32. Pinkerman B, Holroyd K: Comparison of abortive treatment for menstrually related and nonmenstrual migraines in a frequent migraine population: a preliminary report. Headache 2003, 43:512-513.
33. Visser WH, Jaspers NM, de Vriend RH, et al.: Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia 1996, 16:264-269.
34. Facchinetti F, Neri I, Martignoni E, et al.: The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 1993, 13:422-425.
35. Sulak PJ, Scow RD, Preece C, et al.: Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000, 95:261-266.
36. Mannix LK: Management of menstrual migraine. Neurology 2003, 9:207-213.
37. Nappi RE, Sances G, Brundu B, et al.: Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus. Neuroendocrinology 2003, 78:52-60.
38. Fioroni L, Andrea GD, Alecci M, et al.: Platelet serotonin pathway in menstrual migraine. Cephalalgia 1996, 16:427-430.
39. Epstein MT, Hockaday JM, Hockaday TD: Migraine and reproductive hormones throughout the menstrual cycle. Lancet 1975, 1:543-548.
40. Raskin N: Headache, edn 2. New York: Churchhill Livingstone; 1988.
41. Sances G, Martignoni E, Fioroni L, et al.: Naproxen sodium in menstrual migraine prophylaxis: a double-blind, placebo-controlled study. Headache 1990, 30:705-709.
42. Szekely B, Merryman S, Croft H, et al.: Prophylactic effects of naproxen sodium on perimenstrual headache: a double-blind, placebo-controlled study [Abstract]. Cephalalgia 1989, 9(suppl 10):452-453.
43. Gallagher RM: Menstrual migraine and intermittent ergonovine therapy. Headache 1989, 29:366-367.
44. D'Alessandro R, Gamberini G, Lozito, A, et al.: Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine. Cephalalgia 1983, 3(suppl 1):156-158.
45. de Lignieres B, Vincens M, Mauvais-Jarvis P, et al.: Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed) 1986, 293:1540.
46. Dennerstein L, Morse C, Burrows G, et al.: Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988, 2:113-120.
47. MacGregor A, Frith A, Ellis J, et al.: Estrogen "withdrawal:" A trigger for migraine? A double-blind, placebo-controlled study of estrogen supplements in the late luteal phase in women with migraine [Abstract]. Cephalalgia 2003, 23:684.
48. Pfaffenrath V: Efficacy and safety of percutaneous estradiol vs. placebo in menstrual migraine [Abstractl. Cephalalgia 1993, 13(suppl 13):244.
49. Smits MG, van der Meer YG, Pfeil JP, et al.: Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 1994, 34:103-106.
50. Pradalier A, Vincent D, Beaulieu P, et al.: Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. In New Advances in Headache Research, edn 4. Edited by Rose C. London: Smith-Gordon; 1994:129-132.
51. Calhoun A: A novel specific prophylaxis for the estrogen withdrawal migraine [Abstract]. Headache 2003, 43:547.
52. O'Dea JP, Davis EH: Tamoxifen in the treatment of menstrual migraine. Neurology 1990, 40:1470-1471.
53. Mathew P, Fung F: Recapitulation of menstrual migraine with tamoxifen. Lancet 1999, 353:467-468.
54. Newman LC, Lipton RB, Lay CL, et al.: A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998, 51:307-309.
55. Newman L, Mannix LK, Landy S, et al.: Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001, 41:248-256.
56. Dowson A, Brandes J, Loftus J, et al.: Naratriptan as intermittent prophylaxis for menstrually associated migraine (MAM): a review of efficacy and tolerability [Abstract]. Eur J Neurol 2003, 10(suppl 1):73.
57. Silberstein S, Elkind A, Schrieber C: Frovatriptan, a selective 5HT 1D/1B agonist, is effective for prophylaxis of menstrually associated migraine [Abstract]. Neurology 2003, 60:A94.
58. Loder E: Prophylaxis of menstrual migraine with triptans: problems and possibilities. Neurology 2002, 59:1677-1681.
59. Mauskop A, Altura BT, Altura BM: Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache 2002, 42:242-248.
60. Facchinetti F, Sances G, Borella P, et al.: Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991, 31:298-301.
61. Sargent J, Solbach P, Damasio H, et al.: A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache 1985, 25:320-324.
62. Grimes DA, Godwin AJ, Rubin A, et al.: Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial. Obstet Gynecol 1994, 83:29-34.
63. Ryan RE: A controlled study of the effect of oral contraceptives on migraine. Headache 1978, 17:250-251.
64. Whitty CW, Hockaday JM, Whitty MM: The effect of oral contraceptives on migraine. Lancet 1966, 1:856-859.
65. Cachrimanidou AC, Hellberg D, Nilsson S, et al.: Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception 1993, 48:205-216.
66. Martin V, Wernke S, Mandell K, et al.: Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 2003, 43:309-321.
67. Murray SC, Muse KN: Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy. Fertil Steril 1997, 67:390-393.
68. Lichten EM, Bennett RS, Whitty AJ, et al.: Efficacy of danazol in the control of hormonal migraine. J Reprod Med 1991, 36:419-424.
69. Burke BE, Olson RD, Cusack BJ: Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharmacother 2002, 56:283-288.
70. Herzog AG: Continuous bromocriptine therapy in menstrual migraine. Neurology 1997, 48:101-102.